Absence of co-stimulation and not the intensity of TCR signaling is critical for the induction of T cell unresponsiveness in vivo

European Journal of Immunology

Volumn 29, Issue 7, 1999, Pages 2156-2166

  Bachmann, Martin F ^a   Speiser, Daniel E ^b   Mak, Tak W ^b,c   Ohashi, Pamela S ^b  

^a BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c AMGEN INSTITUTE   (Canada)

Author keywords

Altered peptide ligand; Memory; Tolerance; Vacciniation

Indexed keywords

CD28 ANTIGEN; CD8 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; IMMUNOSTIMULATION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD28; CD8-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; IMMUNE TOLERANCE; IMMUNOLOGIC MEMORY; LIGANDS; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, TRANSGENIC; OLIGOPEPTIDES; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; VIRAL PROTEINS;

EID: 0033038791     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199907)29:07<2156::AID-IMMU2156>3.0.CO;2-P     Document Type: Article

References (40)

1. Linsley, P. S. and Ledbetter, J. A., The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 1993. 11: 191-212.
2. Lenschow, D. J., Walunas, T. L. and Bluestone, J., CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 1996. 14: 259-274.
3. Viola, A. and Lanzavecchia, A., T cell activation determined by T cell receptor number and tunable thresholds. Science 1996. 273: 104-106.
4. Bachmann, M. F., McKall-Faienza, K., Schmits, R., Bouchard, D., Beach, J., Speiser, D. E., Mak, T. W. and Ohashi, P. S., Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity 1997. 7: 549-557.
5. Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H. and Allison, J. P., CD28-mediated signalling costimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992. 356: 607-609.
6. Tan, P., Anasetti, C., Hansen, J. A., Melrose, J., Brunvand, M., Bradshaw, J., Ledbetter, J. A. and Linsley, P., Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 1993. 177: 165-173.
7. Boise, L. H., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T. and Thompson, C. B., CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 1995. 3: 87-98.
8. Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Ohashi, P. S., Thompson, C. B. and Mak, T. W., Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993. 261: 609-612.
9. Kündig, T. M., Shahinian, A., Kawai, K., Mittrücker, H.-W., Sebzda, E., Bachmann, M. F., Mak, T. W. and Ohashi, P. S., Duration of TCR Stimulation determines costimulatory requirements. Immunity 1996. 5: 41-52.
10. Brown, D. R., Green, J. M., Moskowitz, N. H., Davis, M., Thompson, C. B. and Reiner, S. L., Limited role of CD28-mediated signals in T helper subset differentiation. J. Exp. Med. 1996. 184: 803-810.
11. Champagne, E., Scarpellino, L., Lane, P. and AchaOrbea, H., CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination. Eur. J. Immunol. 1996. 26: 1595-1602.
12. King, C. L., Xianli, J., June, C. H., Abe, R. and Lee, K. P., CD28-deficient mice generate an impaired Th2 response to Schistosoma mansoni infection. Eur. J. Immunol. 1996. 26: 2448-2455.
13. Mittrucker, H. W., Shahinian, A., Bouchard, D., Kundig, T. M. and Mak, T. W., Induction of unresponsiveness and impaired T cell expansion by staphylococcal enterotoxin B in CD28-deficient mice. J. Exp. Med. 1996. 183: 2481-2488.
14. Lucas, P. J., Negishi, I., Nakayama, K., Fields, L. E. and Loh, D. Y., Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immuneresponse. J. Immunol. 1995. 154: 5757-5768.
15. Bachmann, M. F., Sebzda, E., Kündig, T. M., Shahinian, A., Speiser, D., Mak, T. W. and Ohashi, P. S., T cell responses are governed by avidity and costimulatory thresholds. Eur. J. Immunol. 1996. 26: 2017-2022.
16. Nicholson, L. B., Waldner, H., Carrizoa, A. M., Sette, A., Collins, M. and Kuchroo, V. K., Heteroclitic proliferative response and changes in cytokine profile induced by altered peptides: Implications for autoimmunity. Proc. Natl. Acad. Sci. USA 1998. 95: 264-269.
17. Lenschow, D. J., Ho, S. C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K. C. and Bluestone, J. A., Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 1995. 181.: 1145-1155.
18. Perrin, P. J., Scott, D., Quigley, L., Albert, P. S., Feder, O., Gray, G. S., Abe, R., June, C. H. and Racke, M. K., Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J. Immunol. 1995. 154: 1481-1490.
19. Finck, B. K., Linsley, P. S. and Wofsy, D., Treatment of murine lupus with CTLA4-Ig. Science 1994. 265: 1225-1227.
20. Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S. and Bluestone, J. A., Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992. 257: 789-792.
21. Turka, L. A., Linsley, P. S., Lin, H., Brady, W., Leiden, J. M., Wei, R. Q., Gibson, M. L., Zheng, X. G., Myrdal, S. and Gordon, D., T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA 1992. 89: 11102-11105.
22. Pearson, T. C., Alexander, D. Z., Winn, K. J., Linsley, P. S., Lowry, R. P. and Larsen, C. P., Transplantation tolerance induced by CTLA-4-Ig. Transplantation 1994. 57: 1701-1706.
23. Lin, H., Bolling, S. F., Linsley, P. S., Wei, R.-Q., Gordon, D., Thompson, C. B. and Turka, L. A., Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA-4Ig plus donor-specific transfusion. J. Exp. Med. 1993. 178: 1801-1806.
24. Sloan-Lancaster, J., Evavold, B. D. and Allen, P. M., Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 1993. 363: 156-159.
25. Ryan, K. R. and Evavold, B. D., Persistence of peptide-induced CD4+ T cell anergy in vitro. J. Exp. Med. 1998. 187: 89-96.
26. Wauben, M. H. M., Boog, C. J. P., van der Zee, R., Joosten, I., Schlief, A. and van Eden, W., Disease inhibition by major histocompatibility complex binding peptide analogues of disease associated epitopes: more than just blocking alone. J. Exp. Med. 1992. 176: 667-677.
27. Nicholson, L. B., Greer, J. M., Sobel, R. A., Lees, M. B. and Kuchroo, V. K., An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 1995. 3: 397-405.
28. Pearson, C. I., van Ewijk, W. and McDevitt, H. O., Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T cell receptor transgenic mice. J. Exp. Med. 1997. 185: 583-599.
29. Valitutti, S., Müller, S., Cella, M., Padovan, E. and Lanzavecchia, A., Serial triggering of many T cell receptors by a few peptide-MHC complexes. Nature 1995. 375: 148-151.
30. Bachmann, M. F., Oxenius, A., Speiser, D. E., Mariathasan, S., Hengartner, H., Zinkernagel, R. M. and Ohashi, P. S., Peptide induced TCR-down regulation on naive T cell predicts agonist/partial agonist properties and strictly correlates with T cell activation. Eur. J. Immunol. 1997. 27: 2195-2203.
31. 2+ signals after stimulation of naive T cells with T cell agonists, partial agonists and antagonists. Eur. J. Immunol. 1997. 27: 3414-3419.
32. Zimmermann, C., Brduscha-Riem, K., Blaser, C., Zinkernagel, R. M. and Pircher, H., Visualisation, characterization and turnover of CD8+ memory T cells in virus-infected hosts. J. Exp. Med. 1996. 183: 1367-1375.
33. Hollsberg, P., Weber, W. E., Dangond, F., Batra, V., Sette, A. and Hafler, D. A., Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand. Proc. Natl. Acad. Sci. USA 1995. 92: 4036-4040.
34. Alegre, M. L., Tso, J. Y., Sattar, H. A., Smith, J., Desalle, F., Cole, M. and Bluestone, J. A., An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity. J. Immunol. 1995. 155: 1544-1555.
35. Smith, J. A., Yun Tso, J., Clark, M. R., Cole, M. S. and Bluestone, J. A., Nonmitogenic anti-CD3 monoclonal antibodies deliver a partial T cell receptor signal and induce clonal anergy. J. Exp. Med. 1997. 185: 1413-1422.
36. Smith, J. A., Tank, Q. and Bluestone, J. A., Partial TCR signals delivered by FcR-nonbinding anti-CD3 monoclonal antibodies differentially regulate individual Th subsets. J. Immunol. 1998. 160: 4841-4847.
37. Pircher, H. P., Bürki, K., Lang, R., Hengartner, H. and Zinkernagel, R. M., Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 1989. 342: 559-561.
38. Pircher, H. P., Moskophidis, D., Rohrer, U., Bürki, K., Hengartner, H. and Zinkernagel, R. M., Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 1990. 346: 629-633.
39. Pircher, H. P., Brduscha, K., Steinhoff, U., Kasai, M., Mizuochi, T., Zinkernagel, R. M., Hengartner, H., Kyewski, B. and Müller, K. P., Tolerance induction by clonal deletion of CD4+8+ thymocytes in vitro does not require dedicated antigen presenting cells. Eur. J. Immunol. 1993. 23: 669-674.
40. Bachmann, M. F., Evaluation of lymphocytic choriomeningitis virus-specific cytotoxic T cell responses. In Lefkowitz, I. (Ed.), Immunology Methods Manual. Academic Press Ltd., New York 1997, pp 1921-1933.